Moderator: - Talita Ferreira, Latin America Biowaiver Project Manager, International Pharmaceutical Federation (FIP) - Brazil Panellists: - Maria del Val (Marival) Bermejo Sanz, Professor, Miguel Hernndez University - Spain - Isabel Gonzlez, Professor, Miguel Hernndez University - Spain - Gladys Granero, Professor, University of Crdoba - Argentina - Pablo Gonzlez, CEO, Innovation and Biopharmaceutical Evaluation Center, Chile - Miguel Angel Cabrera-Prez, Associate Professor, Central University of Las Villas, Cuba Watch video Digital event video 12 October 2021, 15:00 - 16:30 CEST FIP WiSE: Women in science and education: Launch of the enabling workplace toolkit More Building on World Health Professions Alliance (WHPA), Positive Practice Environments Campaign, the FIPWiSE toolkit for positive practice environments in education & science is developed to identify and address inequalities in the workplace environments which affects women in pharmaceutical science and pharmacy education, with transferable learnings across the pharmaceutical workforce
Metabolic Pathway Independence Because Semaglutide and Tesamorelin work through completely different receptor systems and metabolic pathways, they do not interfere with each other
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced primarily by intestinal L-cells in response to food intake
As of May 2026, tirzepatide is only available as a subcutaneous injection
